Winner Medical Co., Ltd. (300888.SZ)
CNY 40.96
(0.1%)
CNY 40.96
(0.1%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 4.88 Billion CNY | -19.4% |
| 2022 | 6.05 Billion CNY | 134.73% |
| 2021 | 2.57 Billion CNY | 1.8% |
| 2020 | 2.53 Billion CNY | 85.23% |
| 2019 | 1.36 Billion CNY | 5.4% |
| 2018 | 1.29 Billion CNY | -8.14% |
| 2017 | 1.41 Billion CNY | 118.22% |
| 2016 | 647.45 Million CNY | 74.44% |
| 2015 | 371.15 Million CNY | 1.78% |
| 2014 | 364.67 Million CNY | -9.36% |
| 2013 | 402.32 Million CNY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 4.63 Billion CNY | 6.86% |
| 2024 Q3 | 5.76 Billion CNY | 24.44% |
| 2024 Q1 | 4.33 Billion CNY | -11.2% |
| 2023 Q3 | 5.39 Billion CNY | 4.55% |
| 2023 FY | 4.88 Billion CNY | -19.4% |
| 2023 Q4 | 4.88 Billion CNY | -9.61% |
| 2023 Q1 | 5.43 Billion CNY | -10.26% |
| 2023 Q2 | 5.16 Billion CNY | -4.97% |
| 2022 Q3 | 4.65 Billion CNY | 9.89% |
| 2022 Q1 | 2.78 Billion CNY | 8.01% |
| 2022 FY | 6.05 Billion CNY | 134.73% |
| 2022 Q4 | 6.05 Billion CNY | 30.02% |
| 2022 Q2 | 4.23 Billion CNY | 52.12% |
| 2021 Q4 | 2.57 Billion CNY | 1.15% |
| 2021 Q2 | 2.57 Billion CNY | -0.55% |
| 2021 Q1 | 2.59 Billion CNY | 2.38% |
| 2021 FY | 2.57 Billion CNY | 1.8% |
| 2021 Q3 | 2.55 Billion CNY | -1.15% |
| 2020 Q3 | 2.78 Billion CNY | -17.3% |
| 2020 FY | 2.53 Billion CNY | 85.23% |
| 2020 Q2 | 3.36 Billion CNY | 0.0% |
| 2020 Q4 | 2.53 Billion CNY | -9.02% |
| 2020 Q1 | - CNY | -100.0% |
| 2019 Q1 | 1.16 Billion CNY | 0.0% |
| 2019 FY | 1.36 Billion CNY | 5.4% |
| 2019 Q4 | 1.36 Billion CNY | 0.0% |
| 2019 Q2 | 1.16 Billion CNY | 0.0% |
| 2018 FY | 1.29 Billion CNY | -8.14% |
| 2017 FY | 1.41 Billion CNY | 118.22% |
| 2016 FY | 647.45 Million CNY | 74.44% |
| 2015 FY | 371.15 Million CNY | 1.78% |
| 2014 FY | 364.67 Million CNY | -9.36% |
| 2013 FY | 402.32 Million CNY | 0.0% |